157
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Comparison of two point-of-care respiratory panels for the detection of influenza A/B virus

ORCID Icon, , , , , , ORCID Icon & show all
Pages 509-513 | Received 28 Feb 2023, Accepted 11 May 2023, Published online: 17 May 2023

References

  • Kumar S, Henrickson KJ. Update on influenza diagnostics: lessons from the novel H1N1 influenza a pandemic. Clin Microbiol Rev. 2012;25(2):344–361.
  • Cassidy H, van Genne M, Lizarazo-Forero E, et al. Evaluation of the QIAstat-Dx RP2.0 and the Biofire FilmArray RP2.1 for the rapid detection of respiratory pathogens including SARS-CoV-2. Front Microbiol. 2022;13:854209.
  • Hanson KE, Couturier MR. Multiplexed molecular diagnostics for respiratory, gastrointestinal, and Central nervous system infections. Clin Infect Dis. 2016;63(10):1361–1367.
  • Parčina M, Schneider UV, Visseaux B, et al. Multicenter evaluation of the QIAstat respiratory panel—a new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections. PLOS One. 2020;15(3):e0230183.
  • Berry GJ, Zhen W, Smith E, et al. Multicenter evaluation of the BioFire respiratory panel 2.1 (RP2.1) for detection of SARS-CoV-2 in nasopharyngeal swab samples. J Clin Microbiol. 2022;60(5):e0006622.
  • Echavarría M, Marcone DN, Querci M, et al. Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection. J Clin Virol. 2018;108:90–95.
  • Zhang N, Wang L, Deng X, et al. Recent advances in the detection of respiratory virus infection in humans. J Med Virol. 2020;92(4):408–417.
  • Ramanan P, Bryson AL, Binnicker MJ, et al. Syndromic panel-based testing in clinical microbiology. Clin Microbiol Rev. 2018;31(1):e00024–17.
  • U.S. Food and Drug Administration. 2007. Guidance for industry and FDA Staff - Statistical guidance on reporting results from studies evaluating diagnostic tests. Silver Spring MD: US Food Drug Adm
  • Hazelton B, Gray T, Ho J, et al. Detection of influenza a and B with the AlereTM i influenza a & B: a novel isothermal nucleic acid amplification assay. Influenza Other Respir Viruses. 2015;9(3):151–154.
  • Kim HN, Jang WS, Nam J, et al. Performance evaluation of Alere i influenza a&B in detecting influenza viruses a and B. Ann Clin Lab Sci. 2021;51:106–111.
  • Johnson BF, Leavitt RW, Richards DF. Evaluation of the virocult transport tube for isolation of herpes simplex virus from clinical specimens herpes simplex virus survived in virocult transport tubes and had a half-life of 3.5 days at 2 °C and 2.75 days at 22 °C. Of 2,000 consecutive clinical s. J Clin Microbiol. 1984;20(1):120–122.
  • Svensson MJ, Lind I, Zweygberg Wirgart B, et al. Performance of the simplexaTM flu a/B & RSV direct kit on respiratory samples collected in saline solution. Scand J Infect Dis. 2014;46(12):825–831.
  • Leber AL, Everhart K, Daly JA, et al. Multicenter evaluation of bioFire filmArray respiratory panel 2 for detection of viruses and bacteria in nasopharyngeal swab samples. J Clin Microbiol. 2018;56(6):e01945-17.
  • Leber AL, Lisby JG, Hansen G, et al. Multicenter evaluation of the QIAstat-Dx respiratory panel for detection of viruses and bacteria in nasopharyngeal swab specimens. J Clin Microbiol. 2020;58(5):e00155-20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.